Errors in Prescription Antibiotics in Ventilator-associated Pneumonia

NCT02074033 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2014-03-27

No results posted yet for this study

Summary

The infection is a major risk to hospitalized patients, especially those admitted to the Intensive Care Unit (ICU) and an unfavorable factor in the outcome of critically ill patients, increasing costs and prolonging hospitalization hospitalar. The ventilator-associated pneumonia (PAV) is considered the most prevalent nosocomial infection in the ICU, occurring in 9% to 68% of patients with prosthetic ventilatória.Due to the high rate of PAV and mortality related to it, is very important both prescription and administration of antibiotics correctly, as deescalation or escalation according the result of cultures.Therefore, the objectives of this study is assess if whether the antibiotic prescribed of ventilator-associated pneumonia following the orientation of literature. Will also be assessed the rate of PAV in patients critically ill adults, the main microorganisms responsible by PAV and determining antimicrobial susceptibility.

Conditions

Sponsors & Collaborators

  • Federal University of Uberlandia

    lead OTHER

Principal Investigators

  • Ana Carolina Souza Oliveira · Federal University of Uberlandia

  • Denise Von Dollinger de Brito · Federal University of Uberlandia

  • Thúlio Marquez Cunha · Federal University of Uberlandia

  • Fabiola Alves Gomes · Federal University of Uberlandia

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2014-04-30
Completion
2014-10-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02074033 on ClinicalTrials.gov